Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24511059 | 0.90 | THRA (0.31) | THRATHRB | |
| SCHEMBL6324727 | 0.84 | CYP1A2 (0.36) | — | |
| SCHEMBL6327334 | 0.82 | CYP1A2 (0.38) | — | |
| SCHEMBL6325456 | 0.80 | — | — | |
| SCHEMBL6323595 | 0.78 | MAPT (0.31) | — | |
| SCHEMBL17540097 | 0.75 | THRA (0.31) | THRATHRB | |
| SCHEMBL8050358 | 0.72 | NPC1 (0.39) | — | |
| SCHEMBL406518 | 0.72 | NPC1 (0.39) | — | |
| SCHEMBL7706083 | 0.70 | CCR2 (0.34) | — | |
| SCHEMBL7706087 | 0.70 | CCR2 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220185758-A1 | Oligomeric Materials for UV Blocking Applications and Methods Thereof | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2022-06-16 | — | — | US | disclosed |
| US-20050009928-A1 | Cyclopentanone derivative | ZEON CORPORATION (JP) | 2005-01-13 | — | — | US | disclosed |
| EP-1420005-A1 | CYCLOPENTANONE DERIVATIVE | Zeon Corporation (JP) | 2004-05-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009928-A1 | Cyclopentanone derivative | PTGIS, CYP51A1, TRPA1 | THRA 4868/4885THRB 4872/4885 |
| US-20220185758-A1 | Oligomeric Materials for UV Blocking Applications and Methods Thereof | VCL, PCNA, XRCC5 | THRA 4619/4885THRB 4265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.